Cathie Wood's ARK Investment concentrated its $7.9B AUM across just 20 positions in Q1 2026, unveiling one of its most concentrated portfolios on record. ARK decisively exited non-core assets in ad tech, telecom, and gaming, while doubling down on three structural pillars: AI semiconductors, gene editing, and crypto infrastructure. This rebalancing marks a quarter in which ARK's 'high-conviction, high-concentration' philosophy came into sharpest relief.
Top 5 Holdings — Q1 2026
- TSLA: $1.1B (8.2%)
- AMD: $552M (4.3%)
- CRSP: $538M (4.2%)
- SHOP: $496M (3.9%)
- PLTR: $455M (3.5%)
Key Trading Moves This Quarter
TSLA held its position as the top holding at $1.1B (8.2% of portfolio), with AMD ($552M) and CRSP ($538M) ranking second and third, respectively. AMD's weighting expanded by 5 percentage points quarter-over-quarter, while CRSP surged 8 percentage points — the largest increase in the portfolio — reflecting Wood's deepening conviction in CRISPR gene-editing technology. PLTR, COIN, and HOOD each held roughly 3% weightings, forming a solid AI data and crypto triad anchoring the lower portion of the portfolio.
- AVGO initiated at $126M — a strategic entry targeting demand for custom AI semiconductor design
- CRSP +8pp · AMD +5pp — dual conviction in gene editing and AI chips
- TTD, PD, QCOM, U, FUTU fully exited — complete departure from ad tech, legacy semiconductors, and offshore fintech
Among new purchases, the initiation of AVGO ($126M) stands out. The move directly targets surging demand for custom AI chip design — and, alongside the increased AMD weighting, signals that ARK is making a decisive bet on the AI infrastructure layer. On the sell side, five positions were fully liquidated: TTD ($111M), PD ($109M), QCOM ($43M), and two others. The simultaneous exit from ad tech, enterprise software, and legacy semiconductors reads as a deliberate effort to raise the portfolio's 'innovation purity.'
The Concentration Paradox: What a 20-Stock Portfolio Signals
ARK's decision to compress its holdings to 20 names is a deliberate statement: thematic purity over diversification, even at the cost of higher volatility. With AI infrastructure (AMD, AVGO, PLTR), gene editing (CRSP), and crypto (COIN, HOOD) absorbing a significant share of total AUM, the portfolio is structured to amplify returns if the themes play out — but equally magnify drawdowns if they face headwinds. In Q2, the earnings trajectories of AVGO and CRSP will likely be the decisive variables for overall portfolio performance.
